Phase II Trial of Doxorubicin and Paclitaxel Plus Granulocyte Colony-Stimulating Factor in Metastatic Breast Cancer: An Eastern Cooperative Oncology Group Study PURPOSE: The European Association of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback